Literature DB >> 8173132

Pronounced metabolic response to modest theophylline overdose.

M T Hagley1, S M Traeger, H Schuckman.   

Abstract

OBJECTIVE: To describe a patient who developed significant metabolic abnormalities in response to a low-level theophylline ingestion. CASE
SUMMARY: An 18-year-old man was examined after ingesting theophylline 3 g in a suicide attempt. Although his peak theophylline concentration was 157 mumol/L (28.2 micrograms/mL), it was associated with significant leukocytosis, hypokalemia, hypomagnesemia, hypophosphatemia, hyperglycemia, and lactic acidosis. These abnormalities have been previously associated with theophylline intoxication, but only in conjunction with much higher peak concentrations of theophylline.
CONCLUSIONS: Significant metabolic abnormalities can occur with suicidal ingestion of relatively small amounts of theophylline. The presence of these abnormalities should be sought in theophylline overdoses. In the proper clinical circumstances, such abnormalities should raise suspicion of covert theophylline ingestion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8173132     DOI: 10.1177/106002809402800207

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  4 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Drug-induced disorders of glucose metabolism. Mechanisms and management.

Authors:  J C Chan; C S Cockram; J A Critchley
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

3.  Magnesium metabolism and its disorders.

Authors:  R Swaminathan
Journal:  Clin Biochem Rev       Date:  2003-05

4.  Theophylline toxicity: A case report of the survival of an undiagnosed patient who presented to the emergency department.

Authors:  Nasir Mohamad; Nurkhairul Nizam Abd Halim; Rashidi Ahmad; Kamarul Aryffin Baharuddin
Journal:  Malays J Med Sci       Date:  2009-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.